Parallel Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$973 Buy
+31
New +$1.31K ﹤0.01% 3698
2025
Q4
Sell
-3
Closed -$121 3725
2025
Q3
$121 Hold
3
﹤0.01% 3472
2025
Q2
$77 Sell
3
-13
-81% -$283 ﹤0.01% 3476
2025
Q1
$342 Buy
+16
New +$358 ﹤0.01% 3305
2024
Q1
Sell
-65
Closed -$753 3392
2023
Q4
$753 Buy
65
+30
+86% +$339 ﹤0.01% 2994
2023
Q3
$447 Buy
35
+15
+75% +$213 ﹤0.01% 3123
2023
Q2
$274 Sell
20
-12
-38% -$172 ﹤0.01% 3205
2023
Q1
$490 Buy
32
+13
+68% +$199 ﹤0.01% 3124
2022
Q4
$255 Sell
19
-9
-32% -$121 ﹤0.01% 3153
2022
Q3
$0 Buy
28
+18
+180% +$311 ﹤0.01% 3398
2022
Q2
$0 Hold
10
﹤0.01% 3257
2022
Q1
$0 Hold
10
﹤0.01% 3187
2021
Q4
$0 Sell
10
-15
-60% -$320 ﹤0.01% 3232
2021
Q3
$1K Buy
25
+15
+150% +$361 ﹤0.01% 2923
2021
Q2
$0 Buy
+10
New +$270 ﹤0.01% 3028
2020
Q2
Sell
-21
Closed 2640
2020
Q1
$0 Hold
21
﹤0.01% 2579
2019
Q4
$1K Buy
+21
New +$487 ﹤0.01% 2332

Other funds holding PAHC

Parallel Advisors's PAHC Position: Q2 2026 in Review

Parallel Advisors opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 31 shares worth $973. The stake represents ﹤0.01% of the portfolio and ranks #3698 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in PAHC as recently as Q3 2025.

Parallel Advisors first reported a position in PAHC in Q4 2019 and has held it in 17 quarters since. The position peaked at $1K in Q3 2021. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Parallel Advisors held 31 shares of Phibro Animal Health worth $973 as of Q2 2026.
  • Phibro Animal Health was a new Parallel Advisors position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3698 holding.
  • Parallel Advisors first reported a position in Phibro Animal Health in Q4 2019 and has held it in 17 quarters since.
  • Parallel Advisors's Phibro Animal Health position peaked at $1K in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.